VIR BIOTECHNOLOGY INC's ticker is and the CUSIP is 92764N902. A total of 5 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $281,100 | -90.0% | 30,000 | -73.9% | 0.00% | – |
Q2 2023 | $2,823,403 | +267.6% | 115,100 | +248.8% | 0.00% | – |
Q1 2023 | $768,000 | +297.9% | 33,000 | +617.4% | 0.00% | – |
Q4 2021 | $193,000 | -77.1% | 4,600 | -74.2% | 0.00% | – |
Q2 2021 | $842,000 | -34.3% | 17,800 | -28.8% | 0.00% | – |
Q1 2021 | $1,282,000 | – | 25,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 50,500 | $1,175,135 | 0.00% |
SIMPLEX TRADING, LLC | 49,000 | $1,140 | 0.00% |
JPMORGAN CHASE & CO | 33,000 | $768,000 | 0.00% |
JANE STREET GROUP, LLC | 48,900 | $1,137,903 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |